Locally produced AstraZeneca vaccine passes inspection
THURSDAY, MAY 27, 2021
Nine production lots of the AstraZeneca vaccine manufactured by Siam Bioscience passed a quality inspection conducted by the Department of Medical Sciences on May 25, department director-general Dr Supphakit Siriluck said on Wednesday.
First 9 batches of Thai-made AstraZeneca jabs pass quality checks
WEDNESDAY, MAY 26, 2021
The first nine batches of AstraZeneca vaccine produced in Thailand have passed official quality checks, the Department of Medical Sciences (DMS) announced on Wednesday.
AstraZeneca’s COVID-19 vaccines made by Siam Bioscience pass quality testing in Europe and U.S., first batch delivery is near
SUNDAY, MAY 09, 2021
AstraZeneca announced today that the samples from test batches of the COVID-19 vaccine made by Siam Bioscience had passed the quality testing at AstraZeneca’s designated laboratories in Europe and in the U.S.
Siam Bioscience breaks silence on vaccine deal after Thanathorn criticism
MONDAY, JANUARY 25, 2021
Siam Bioscience on Monday released a statement following criticism by Progressive Movement leader Thanathorn Juangroongruangkit over its role in Thailand’s Covid-19 vaccine programme.
Thailand to launch vaccine production ‘in first half of 2021’
TUESDAY, NOVEMBER 24, 2020
AstraZeneca’s Covid-19 vaccine should be available in Thailand in the first half of 2021, under a technology-transfer deal signed with the Thai government.
Anutin vows to have half of population jabbed once Covid-19 vaccine released
MONDAY, OCTOBER 19, 2020
Siam Bioscience Group has been chosen to produce the Covid-19 vaccine once the human trials conducted by Oxford University and AstraZeneca prove to be successful.
SIAM Bioscience Co has formed a 70:30 joint venture with the Cuba-based Centre of Molecular Immunology to research and develop biopharmaceuticals for cancer and auto-immune diseases worth up to Bt3 billion this year.